| Name | Title | Contact Details |
|---|
Our vision is to serve our communities’ evolving healthcare needs by cultivating a network of compassionate, dedicated professionals. We are committed to working together, using best practices, improving quality, and assuring an exceptional patient experience. Our highest priority is caring for people - the friends, family and neighbors whom we serve in our community. We are committed to providing an environment based on respect and one which encourages personal and profession growth.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.
Southern Medical Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Agility Healthcare Solutions is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).